Posted on 10 January 2013 by dmishesq
K-V Pharmaceutical, whose stock recently plummeted, has come up with a
bankruptcy exit plan that will hopefully enable the struggling company to remain
in business. Senior noteholders have already approved of the plan, even though
it depends on a $20 million dollar rights offering. Whitebox Advisors, Pioneer
Investment Management and Silver Point Capital are the key lenders working with
the company on the plan. K-V Pharmaceutical originally filed for bankruptcy in
August of 2012.
Read the full article here:
The Daily Docket: K-V Pharmaceutical Unveils Bankruptcy Plan
Read the full article here:
The Daily Docket: K-V Pharmaceutical Unveils Bankruptcy Plan
No comments:
Post a Comment